Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 2.04 | - |
NAV | ₹13.22 | - |
Fund Started | 10 Apr 2024 | - |
Fund Size | ₹1915.00 Cr | - |
Exit Load | Exit load of 0.50%, if redeemed within 30 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 8.52% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 99.44% | - |
Cash | 0.55% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
One97 Communications Ltd. | 5.88% |
Eternal Ltd. | 5.10% |
Astrazeneca Pharma India Ltd. | 3.79% |
Bajaj Finserv Ltd. | 3.24% |
Reliance Industries Ltd. | 3.04% |
Jubilant Ingrevia Ltd. | 2.69% |
GE Vernova T&D India Ltd | 2.53% |
Coforge Ltd. | 2.48% |
Varun Beverages Ltd. | 2.39% |
Info Edge (India) Ltd. | 2.25% |
Name | Prateek Poddar | - |
Start Date | 07 Jun 2024 | - |
Name
Start Date
Description | The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies following innovation theme. | - |
Launch Date | 10 Apr 2024 | - |
Description
Launch Date